Skip to Main Content

Paper Details

Nephrotic-range proteinuria in type 2 diabetes: Effects of empagliflozin on kidney disease progression and clinical outcomes.
EClinicalMedicine
7
2021
Author NameAffiliation
Bernard ZinmanLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, and University of Toronto
  • 1 - 1

Datasets

Release 1.2